Safety and efficacy of single agent rovalpituzumab tesirine in small cell lung cancer (SCLC)

1 Views
administrator
administrator
07/14/23

Press brief by Charles Rudin, MD, PhD of the Memorial Sloan Kettering Cancer Center, New York, NY, at the 2016 Annual Meeting of the American Society of Clinical Oncology (ASCO), held in Chicago, IL.

Show more

0 Comments Sort By

No comments found

Facebook Comments

Up next